Provided by Tiger Trade Technology Pte. Ltd.

Sutro Biopharma Inc

15.60
-0.9600-5.80%
Post-market: 15.610.0100+0.06%17:33 EDT
Volume:273.30K
Turnover:4.31M
Market Cap:258.45M
PE:-0.90
High:16.80
Open:16.66
Low:15.17
Close:16.56
52wk High:43.85
52wk Low:7.15
Shares:16.57M
Float Shares:10.77M
Volume Ratio:0.49
T/O Rate:2.54%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-17.3700
EPS(LYR):-22.4900
ROE:-1810.01%
ROA:-36.08%
PB:-2.50
PE(LYR):-0.69

Loading ...

Sutro Biopharma Inc : Truist Securities Assumes Coverage With Buy Rating; Target Price $50

THOMSON REUTERS
·
Jun 11

Sutro Biopharma shareholders adopt director elections at annual meeting

Reuters
·
Jun 09

Sutro Biopharma Initiated at Overweight by Barclays

Dow Jones
·
May 28

Industry Analysts Just Upgraded Their Sutro Biopharma, Inc. (NASDAQ:STRO) Revenue Forecasts By 46%

Simply Wall St.
·
May 28

Barclays Initiates a Buy Rating on Sutro Biopharma (STRO)

TIPRANKS
·
May 28

H.C. Wainwright Remains a Buy on Sutro Biopharma (STRO)

TIPRANKS
·
May 27

Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC) and Sutro Biopharma (STRO)

TIPRANKS
·
May 22

Sutro Biopharma Inc : Piper Sandler Raises Target Price to $61 From $29

THOMSON REUTERS
·
May 18

Sutro Biopharma Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 15

Wedbush Upgrades Sutro Biopharma to Outperform From Neutral, Boosts Price Target to $60 From $22

MT Newswires Live
·
May 15

Sutro Biopharma price target raised to $43 from $38 at Leerink

TIPRANKS
·
May 15

Sutro Biopharma, Inc. : H.c. Wainwright Raises Target Price to $50 From $28

THOMSON REUTERS
·
May 15

Analyst Reiterates Buy on Sutro Biopharma, Citing STRO-004 Phase I Readout and Broader ADC Platform Potential

TIPRANKS
·
May 15

Sutro Biopharma Q1 EPS $(2.94) Beats $(3.77) Estimate, Sales $14.523M Beat $8.079M Estimate

Benzinga Earnings
·
May 15

Sutro Biopharma Q1 net loss narrows 49% to $38.48 million; revenue falls 17% to $14.52 million

Reuters
·
May 15

Sutro Biopharma Q1 Loss Narrows, Revenue Declines

MT Newswires Live
·
May 15

BRIEF-Sutro Biopharma Q1 Revenue USD 14.523 Million Vs. IBES Estimate USD 8.08 Million

Reuters
·
May 15

Sutro Biopharma Reports First Quarter 2026 Financial Results and Business Highlights

GlobeNewswire
·
May 15

Sutro Biopharma Inc expected to post a loss of $3.77 a share - Earnings Preview

Reuters
·
May 04

LifeSci Capital Initiates a Buy Rating on Sutro Biopharma (STRO)

TIPRANKS
·
May 01